On-X Ascending Aortic Prosthesis
On-X Life Technologies, Inc. · Decision date Dec 17, 2025
What did the FDA decide?
FDA records P000037/S067 as a supplement to PMA P000037, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 17, 2025.
FDA approval order statement
to increase the blue soiling acceptance criteria limit for the vascular prosthesis component of the On-X Ascending Aorta Prosthesis
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 17, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P000037/S067
- Regulatory pathway
- PMA supplement
- Applicant
- On-X Life Technologies, Inc.
- Product code
- LWQ
- Decision code
- OK30
- Decision date
- Dec 17, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: HEART-VALVE, MECHANICAL.
- Applicant
- On-X Life Technologies, Inc.
- Product code
- LWQ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P000037/S063 · Related supplement
On-X Heart Valve; On-X Ascending Aortic Prosthesis
P000037/S064 · Related supplement
On-X Prosthetic Heart Valves; On-X Ascending Aortic Prothesis
P000037/S065 · Related supplement
On-X Prosthetic Heart Valves and Ascending Aortic Prothesis
P000037/S066 · Related supplement
On-X Prosthetic Heart Valves and Ascending Aortic Prothesis (AAP)
P000037/S067 received
Application receipt date recorded by FDA.
P000037/S067 · FDA decision
30-Day Notice
P000037/S068 · Related supplement
On-X Prosthetic Heart Valves and Ascending Aortic Prothesis
P000037/S070 · Related supplement
On-X Prosthetic Heart Valves and Ascending Aortic Prothesis
P000037/S071 · Related supplement
On-X Prosthetic Heart Valves and Ascending Aortic Prothesis (On-X AAP)
Timeline entries are records held by MedtechLedger for P000037. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P000037
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| On-X Life Technologies, Inc. | PMA supplement | Oct 22, 2025 | FDA | |
| On-X Life Technologies, Inc. | PMA supplement | Oct 22, 2025 | FDA | |
| On-X Life Technologies, Inc. | PMA supplement | Oct 22, 2025 | FDA | |
| On-X Life Technologies, Inc. | PMA supplement | Oct 22, 2025 | FDA | |
| On-X Life Technologies, Inc. | PMA supplement | Jan 5, 2026 | FDA | |
| On-X Life Technologies, Inc. | PMA supplement | Jul 27, 2026 | FDA | |
| On-X Life Technologies, Inc. | PMA supplement | Aug 4, 2026 | FDA |
Explore the linked device profile
Other records with product code LWQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Corcym S.r.l. | PMA supplement | Jul 28, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Jun 11, 2026 | FDA | |
| Corcym S.r.l. | PMA supplement | Dec 17, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
On-X Life Technologies, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1655 Roberts Blvd. NW, Kennesaw, GA, 30144
Sources and methodology
- Original FDA record: P000037/S067
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records